Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis
In 2009, vinflunine was introduced as a second-line treatment to be used after the failure of platinum therapy in patients with metastatic urothelial carcinoma (mUC). The present study investigated the administered vinflunine to patients with mUC in standard clinical practice with the aim of evaluat...
Main Authors: | Holmsten, Karin, Dohn, Line, Jensen, Niels Viggo, Shah, Carl-Henrik, Jäderling, Fredrik, Pappot, Helle, Ullén, Anders |
---|---|
Format: | Online |
Language: | English |
Published: |
D.A. Spandidos
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950730/ |
Similar Items
-
Critical evaluation of vinflunine in the treatment of refractory metastatic urothelial carcinoma
by: Morel, Armand, et al.
Published: (2010) -
Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experience
by: Retz, Margitta, et al.
Published: (2015) -
Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01–2014)
by: Rodolfo Passalacqua, et al.
Published: (2017-07-01) -
The impact of prior platinum therapy on survival in patients with metastatic urothelial cancer receiving vinflunine
by: Harshman, L C, et al.
Published: (2013) -
Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study
by: Médioni, Jacques, et al.
Published: (2016)